CD37-binding molecules and immunoconjugates thereof Grant US-11466095-B2 United States of America 11 Oct 2022
Anti-CD37 immunoconjugate and anti-CD20 antibody combinations Grant US-11395796-B2 United States of America 26 Jul 2022
Methods for improving anti-CD37 immunoconjugate therapy Grant US-11278629-B2 United States of America 22 Mar 2022
Methods and therapeutics comprising ligand-targeted ELPs Grant US-11224662-B2 United States of America 18 Jan 2022
Antibodies and assays for detection of CD37 Grant US-11104740-B2 United States of America 31 Aug 2021
B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATES Application WO-2021074261-A1 World Intellectual Property Organisation (WIPO) 22 Apr 2021
CD37-binding molecules and immunoconjugates thereof Grant US-10556958-B2 United States of America 11 Feb 2020
CD37-binding molecules and immunoconjugates thereof Grant US-9447189-B2 United States of America 20 Sep 2016
CD37-binding molecules and immunoconjugates thereof Grant US-9346887-B2 United States of America 24 May 2016
CD37-binding molecules and immunoconjugates thereof Grant US-8765917-B2 United States of America 01 Jul 2014
CD20 scFv-ELPs METHODS AND THERAPEUTICS Application WO-2014026054-A3 World Intellectual Property Organisation (WIPO) 05 Jun 2014
EXTRACELLULAR TARGETED DRUG CONJUGATES Application US-20140079722-A1 United States of America 20 Mar 2014
CD20 scFv-ELPs METHODS AND THERAPEUTICS Application WO-2014026054-A2 World Intellectual Property Organisation (WIPO) 13 Feb 2014